Donna J. Affleck

692 total citations
29 papers, 542 citations indexed

About

Donna J. Affleck is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Epidemiology. According to data from OpenAlex, Donna J. Affleck has authored 29 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Neurology and 8 papers in Epidemiology. Recurrent topics in Donna J. Affleck's work include Radiopharmaceutical Chemistry and Applications (20 papers), Neuroblastoma Research and Treatments (14 papers) and Medical Imaging Techniques and Applications (12 papers). Donna J. Affleck is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Neuroblastoma Research and Treatments (14 papers) and Medical Imaging Techniques and Applications (12 papers). Donna J. Affleck collaborates with scholars based in United States, Germany and Canada. Donna J. Affleck's co-authors include Michael R. Zalutsky, Ganesan Vaidyanathan, Darell D. Bigner, Kevin L. Alston, Jean Li, Philip Welsh, Xiaoguang Zhao, Margret Schottelius, Henry S. Friedman and Susan Slade and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioconjugate Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Donna J. Affleck

29 papers receiving 530 citations

Peers

Donna J. Affleck
Johan Spetz Sweden
Ganghua Tang China
Kristell L.S. Chatalic Netherlands
PL Jager Netherlands
Vincent A. DiPippo United States
Sarah Pfaff Austria
Toshimi Sato Japan
Shorouk Dannoon United States
Kwang Il Kim South Korea
Sadahiro Naka Japan
Johan Spetz Sweden
Donna J. Affleck
Citations per year, relative to Donna J. Affleck Donna J. Affleck (= 1×) peers Johan Spetz

Countries citing papers authored by Donna J. Affleck

Since Specialization
Citations

This map shows the geographic impact of Donna J. Affleck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna J. Affleck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna J. Affleck more than expected).

Fields of papers citing papers by Donna J. Affleck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna J. Affleck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna J. Affleck. The network helps show where Donna J. Affleck may publish in the future.

Co-authorship network of co-authors of Donna J. Affleck

This figure shows the co-authorship network connecting the top 25 collaborators of Donna J. Affleck. A scholar is included among the top collaborators of Donna J. Affleck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna J. Affleck. Donna J. Affleck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaidyanathan, Ganesan, Donna J. Affleck, Xiao-Guang Zhao, et al.. (2012). SIB-DOTA: A trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies. Bioorganic & Medicinal Chemistry. 20(24). 6929–6939. 9 indexed citations
2.
Vaidyanathan, Ganesan, et al.. (2010). Radioiodinated O6-Benzylguanine derivatives containing an azido function. Nuclear Medicine and Biology. 38(1). 77–92. 9 indexed citations
3.
Vaidyanathan, Ganesan, Donna J. Affleck, Xiaoguang Zhao, Stephen T. Keir, & Michael R. Zalutsky. (2010). [177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma. Current Radiopharmaceuticals. 3(1). 29–36. 5 indexed citations
4.
Vaidyanathan, Ganesan, Haijing Song, Donna J. Affleck, et al.. (2009). Targeting aldehyde dehydrogenase: a potential approach for cell labeling. Nuclear Medicine and Biology. 36(8). 919–929. 9 indexed citations
5.
Vaidyanathan, Ganesan, Donna J. Affleck, Kevin L. Alston, et al.. (2007). A kit method for the high level synthesis of [211At]MABG. Bioorganic & Medicinal Chemistry. 15(10). 3430–3436. 42 indexed citations
6.
Vaidyanathan, Ganesan, et al.. (2005). Synthesis and Evaluation of Glycosylated Octreotate Analogues Labeled with Radioiodine and 211At via a Tin Precursor. Bioconjugate Chemistry. 17(1). 195–203. 25 indexed citations
7.
Vaidyanathan, Ganesan, Donna J. Affleck, & Michael R. Zalutsky. (2004). No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue. Applied Radiation and Isotopes. 62(3). 435–440. 7 indexed citations
8.
Vaidyanathan, Ganesan, Donna J. Affleck, Kevin L. Alston, Philip Welsh, & Michael R. Zalutsky. (2004). Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells. Nuclear Medicine Communications. 25(9). 947–955. 4 indexed citations
9.
10.
Vaidyanathan, Ganesan, et al.. (2004). Meta-iodobenzylguanidine derivatives containing a second guanidine moiety. Bioorganic & Medicinal Chemistry. 12(7). 1649–1656. 11 indexed citations
11.
Vaidyanathan, Ganesan, Donna J. Affleck, Joseph Norman, et al.. (2004). O6-3-[131I]iodobenzylguanine:  Improved Synthesis and Further Evaluation of a Potential Agent for Imaging of Alkylguanine-DNA Alkyltransferase. Bioconjugate Chemistry. 15(2). 402–408. 7 indexed citations
12.
Vaidyanathan, Ganesan, Donna J. Affleck, Darell D. Bigner, & Michael R. Zalutsky. (2003). N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with α-particle emitting 211At. Nuclear Medicine and Biology. 30(4). 351–359. 47 indexed citations
13.
14.
Vaidyanathan, Ganesan, Donna J. Affleck, Darell D. Bigner, & Michael R. Zalutsky. (2002). Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate. Nuclear Medicine and Biology. 29(1). 1–11. 31 indexed citations
15.
Vaidyanathan, Ganesan, et al.. (2001). Biological Evaluation of Ring- and Side-Chain-Substituted m-Iodobenzylguanidine Analogues. Bioconjugate Chemistry. 12(5). 798–806. 14 indexed citations
16.
Vaidyanathan, Ganesan, Donna J. Affleck, Philip Welsh, et al.. (2000). Radioiodination and astatination of octreotide by conjugation labeling. Nuclear Medicine and Biology. 27(4). 329–337. 20 indexed citations
17.
Zalutsky, Michael R., Feng Xu, Yu Yin, et al.. (1999). Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution. Nuclear Medicine and Biology. 26(7). 781–790. 24 indexed citations
18.
Vaidyanathan, Ganesan, Donna J. Affleck, & Michael R. Zalutsky. (1994). (4-[18F]Fluoro-3-iodobenzyl)guanidine, a Potential MIBG Analog for Positron Emission Tomography. Journal of Medicinal Chemistry. 37(21). 3655–3662. 40 indexed citations
19.
Vaidyanathan, Ganesan, Donna J. Affleck, & Michael R. Zalutsky. (1994). Monoclonal antibody f(ab′)2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: In vivo comparison of iodinated and astatinated fragments. Nuclear Medicine and Biology. 21(1). 105–110. 7 indexed citations
20.
Vaidyanathan, Ganesan, Donna J. Affleck, & Michael R. Zalutsky. (1993). Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate. Bioconjugate Chemistry. 4(1). 78–84. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johan Spetz Breakdown of academic impact, for papers by Ganghua Tang Breakdown of academic impact, for papers by Kristell L.S. Chatalic Breakdown of academic impact, for papers by PL Jager Breakdown of academic impact, for papers by Vincent A. DiPippo Breakdown of academic impact, for papers by Sarah Pfaff Breakdown of academic impact, for papers by Toshimi Sato Breakdown of academic impact, for papers by Shorouk Dannoon Breakdown of academic impact, for papers by Kwang Il Kim Breakdown of academic impact, for papers by Sadahiro Naka
Rankless by CCL
2026